A dual antibody test for accurate surveillance of SARS-CoV-2 exposure rates

Hippich, 2021, A Public Health Antibody Screening Indicates a 6-Fold Higher SARS-CoV-2 Exposure Rate than Reported Cases in Children, Med, 2, 149, 10.1016/j.medj.2020.10.003 Pollán, 2020, Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study, Lancet, 396, 535, 10.1016/S0140-6736(20)31483-5 Riccò, 2020, Point-of-Care Diagnostic Tests for Detecting SARS-CoV-2 Antibodies: A Systematic Review and Meta-Analysis of Real-World Data, J. Clin. Med., 9, 1515, 10.3390/jcm9051515 Xu, 2020, Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China, Nat. Med., 26, 1193, 10.1038/s41591-020-0949-6 Sood, 2020, Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020, JAMA, 323, 2425, 10.1001/jama.2020.8279 Kumleben, 2020, Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers, Public Health, 185, 88, 10.1016/j.puhe.2020.06.006 Salje, 2020, Estimating the burden of SARS-CoV-2 in France, Science, 369, 208, 10.1126/science.abc3517 Rubino, 2020, New-Onset Diabetes in Covid-19, N. Engl. J. Med., 383, 789, 10.1056/NEJMc2018688